what is the bmi requirement for glp 1 criteria Sharing a chart from next issue of Plain Medicine, my Who Actually Qualifies For GLP-1

What Are Common Side Effects, Including Nausea

"But we have to be fiduciary responsible to people who are paying premiums to that."

From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies

Research-grade products

A big part of the problem starts with Medicare